Cargando…
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and low grade inflammation and the risk for cardiovascular disease (CVD) could be increased in PCOS. METHODS: National register-based study including women with PCOS and no previous diagnosis of CVD, hypertension, or dyslipidemi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844097/ https://www.ncbi.nlm.nih.gov/pubmed/29519249 http://dx.doi.org/10.1186/s12933-018-0680-5 |
_version_ | 1783305196672122880 |
---|---|
author | Glintborg, Dorte Rubin, Katrine Hass Nybo, Mads Abrahamsen, Bo Andersen, Marianne |
author_facet | Glintborg, Dorte Rubin, Katrine Hass Nybo, Mads Abrahamsen, Bo Andersen, Marianne |
author_sort | Glintborg, Dorte |
collection | PubMed |
description | BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and low grade inflammation and the risk for cardiovascular disease (CVD) could be increased in PCOS. METHODS: National register-based study including women with PCOS and no previous diagnosis of CVD, hypertension, or dyslipidemia. PCOS Denmark (N = 18,112) included women with PCOS in the Danish National Patient Register. PCOS Odense University Hospital (OUH, N = 1165) was an embedded cohort including premenopausal women with PCOS and clinical and biochemical examination. Three age-matched controls were included per patient in PCOS Denmark (N = 52,769). The main study outcome was CVD events including hypertension and dyslipidemia defined according to nationwide in- and outpatient hospital contact diagnosis codes and/or inferred from filled medicine prescriptions. RESULTS: The age at inclusion was median (quartiles) 29 (23–35) years and follow up was 11.1 (6.9–16.0) years. The Hazard ratio (95% CI) for development of CVD in PCOS Denmark was 1.7 (1.7; 1.8) (P < 0.001) and the total event rate of CVD was 22.6 per 1000 patient years in PCOS Denmark vs. 13.2 per 1000 patient years in controls (P < 0.001). The median age at diagnosis of CVD was 35 (28–42) years in PCOS Denmark vs. 36 (30–43) years in controls (P < 0.001). Obesity, diabetes, and infertility, and previous use of oral contraceptives were associated with increased risk of development of CVD in PCOS Denmark (P < 0.001). Women in PCOS OUH resembled women in PCOS Denmark regarding risk of CVD. Age, BMI, blood pressure, lipid status, and glycemic status predicted development of CVD in PCOS OUH. CONCLUSION: The event rate of CVD including hypertension and dyslipidemia was higher in PCOS compared to controls. The risk of developing CVD must be considered even in young women with PCOS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12933-018-0680-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5844097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58440972018-03-14 Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome Glintborg, Dorte Rubin, Katrine Hass Nybo, Mads Abrahamsen, Bo Andersen, Marianne Cardiovasc Diabetol Original Investigation BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and low grade inflammation and the risk for cardiovascular disease (CVD) could be increased in PCOS. METHODS: National register-based study including women with PCOS and no previous diagnosis of CVD, hypertension, or dyslipidemia. PCOS Denmark (N = 18,112) included women with PCOS in the Danish National Patient Register. PCOS Odense University Hospital (OUH, N = 1165) was an embedded cohort including premenopausal women with PCOS and clinical and biochemical examination. Three age-matched controls were included per patient in PCOS Denmark (N = 52,769). The main study outcome was CVD events including hypertension and dyslipidemia defined according to nationwide in- and outpatient hospital contact diagnosis codes and/or inferred from filled medicine prescriptions. RESULTS: The age at inclusion was median (quartiles) 29 (23–35) years and follow up was 11.1 (6.9–16.0) years. The Hazard ratio (95% CI) for development of CVD in PCOS Denmark was 1.7 (1.7; 1.8) (P < 0.001) and the total event rate of CVD was 22.6 per 1000 patient years in PCOS Denmark vs. 13.2 per 1000 patient years in controls (P < 0.001). The median age at diagnosis of CVD was 35 (28–42) years in PCOS Denmark vs. 36 (30–43) years in controls (P < 0.001). Obesity, diabetes, and infertility, and previous use of oral contraceptives were associated with increased risk of development of CVD in PCOS Denmark (P < 0.001). Women in PCOS OUH resembled women in PCOS Denmark regarding risk of CVD. Age, BMI, blood pressure, lipid status, and glycemic status predicted development of CVD in PCOS OUH. CONCLUSION: The event rate of CVD including hypertension and dyslipidemia was higher in PCOS compared to controls. The risk of developing CVD must be considered even in young women with PCOS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12933-018-0680-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-08 /pmc/articles/PMC5844097/ /pubmed/29519249 http://dx.doi.org/10.1186/s12933-018-0680-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Glintborg, Dorte Rubin, Katrine Hass Nybo, Mads Abrahamsen, Bo Andersen, Marianne Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome |
title | Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome |
title_full | Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome |
title_fullStr | Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome |
title_full_unstemmed | Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome |
title_short | Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome |
title_sort | cardiovascular disease in a nationwide population of danish women with polycystic ovary syndrome |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844097/ https://www.ncbi.nlm.nih.gov/pubmed/29519249 http://dx.doi.org/10.1186/s12933-018-0680-5 |
work_keys_str_mv | AT glintborgdorte cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome AT rubinkatrinehass cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome AT nybomads cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome AT abrahamsenbo cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome AT andersenmarianne cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome |